Cardiac myosin-Th17 responses promote heart failure in human myocarditis

J. Martin Myers(University of Oklahoma Health Sciences Center), Madeleine W. Cunningham(University of Oklahoma Health Sciences Center), David C. Kem(University of Oklahoma Health Sciences Center), Leslie T. Cooper(WinnMed), Stanley D. Kosanke(University of Oklahoma Health Sciences Center), Stavros Stavrakis(University of Oklahoma Health Sciences Center), DeLisa Fairweather(Mayo Clinic), Ethan M. Shevach(National Institutes of Health), Julie A. Stoner(University of Oklahoma Health Sciences Center), Carol J. Cox(University of Oklahoma Health Sciences Center)
JCI Insight
June 15, 2016
10.1172/jci.insight.85851
Cited by 226

Related Papers

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Induction of FOXP3 expression in naive human CD4+FOXP3− T cells by T-cell receptor stimulation is transforming growth factor-β–dependent but does not confer a regulatory phenotype
|Blood|2007|733
Sex Differences in Autoimmune Disease from a Pathological Perspective
|American Journal Of Pathology|2008|623
Recognition and Initial Management of Fulminant Myocarditis
|Circulation|2020|593
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553